Vaccine Safety, Adverse Events, and Contraindications
Vaccine safety is the field within vaccinology concerned with detecting, characterizing, and interpreting unwanted effects that follow immunization, and with the decision rules — contraindications and precautions — that govern who should not receive a given vaccine. Because vaccines are given to very large numbers of mostly healthy people, the discipline weighs even uncommon harms against the population benefit of preventing disease.
Definition
Vaccine safety is the systematic study and surveillance of adverse events following immunization (AEFI) — including their detection, classification, causality assessment, and risk communication — together with the contraindications and precautions that define when vaccination should be withheld or deferred.
Scope
This area orients the reader to how immunization safety is conceptualized and monitored: the distinction between expected reactogenicity and true adverse events, the surveillance systems and standardized case definitions used to capture events, the causality assessment that separates association from causation, and the contraindications that translate safety knowledge into clinical eligibility. It is a reference overview; the detailed essentials live in its topic nodes.
Sub-topics
Core questions
- How are adverse events following immunization detected, classified, and reported?
- Which post-vaccination effects are expected reactogenicity and which are true adverse events?
- How is a causal link between a vaccine and an event distinguished from coincidental temporal association?
- What conditions constitute a contraindication or precaution for a given vaccine?
- How should the population benefit of vaccination be weighed against rare serious harms?
Key concepts
- Adverse event following immunization (AEFI)
- Reactogenicity
- Contraindication and precaution
- Pharmacovigilance and post-marketing surveillance
- Standardized (Brighton) case definitions
- Causality assessment
- Benefit-risk balance
- Vaccine confidence and risk communication
Mechanisms
Unwanted effects after vaccination span a spectrum. Most are reactogenicity — the expected, self-limited inflammatory response to the vaccine and its adjuvant — while a smaller set are true adverse events that may be coincidental, caused by the product, or caused by errors in handling or administration. Surveillance systems collect spontaneous and active reports, standardized case definitions make events comparable across studies, and causality assessment uses temporal, biological, and epidemiological criteria to judge whether a vaccine plausibly caused an event. Knowledge of established harms and of host factors then feeds the contraindications and precautions that determine clinical eligibility.
Clinical relevance
Understanding vaccine safety underpins informed consent, eligibility screening, and public trust in immunization programs. It explains why surveillance continues after licensure and how rare risks are detected and contextualized. This area describes how safety evidence is generated and interpreted at the population level; it is not a substitute for product-specific labeling or individualized clinical judgement.
Epidemiology
Because serious vaccine adverse events are rare, their detection often requires very large linked databases or pooled surveillance, and observed rates must be compared with background rates in unvaccinated populations to separate causation from coincidence. Independent causality reviews, such as the U.S. Institute of Medicine's evidence syntheses, have found convincing evidence for some vaccine-event relationships and insufficient evidence for many others, illustrating how the field handles uncertainty.
History
Organized vaccine safety surveillance grew alongside mass immunization in the twentieth century, with passive reporting systems established to catch unexpected events after licensure. The founding of the Brighton Collaboration in 2000 introduced standardized case definitions so that events could be compared across countries and studies, and large independent evidence reviews have periodically assessed the causality of specific vaccine-event associations.
Key figures
- Robert Chen
- Jan Bonhoeffer
- Tom Shimabukuro
- Heidi Larson
Related topics
Seminal works
- bonhoeffer-2002
- iom-2012
- herve-2019
Frequently asked questions
- What is the difference between a side effect and an adverse event following immunization?
- An adverse event following immunization (AEFI) is any untoward medical occurrence after vaccination, whether or not it is caused by the vaccine; causality assessment then determines whether the vaccine plausibly caused it. Expected, self-limited reactions such as a sore arm or low-grade fever are usually classified as reactogenicity.
- Does a temporal association mean a vaccine caused an event?
- No. Because vaccines are given to large populations, some health events will occur shortly after vaccination by chance. Causality assessment compares observed rates with background rates and applies biological and epidemiological criteria before inferring cause.